- Renovo Group PLC
- Entelos Inc.
- Hutchison China MediTech Ltd.
- Medarex Inc.
- Cougar Biotechnology Inc.
- TorreyPines Therapeutics Inc.
- Ziopharm Oncology Inc.
- Novartis AG
- NeuTec Pharma Ltd.
- AstraZeneca PLC
- Cambridge Antibody Technology Group PLC
- Affymax Inc.
- Takeda Pharmaceutical Co. Ltd.
- Vertex Pharmaceuticals Inc.
- Johnson & Johnson
- Janssen R&D Ireland
- Janssen Pharmaceutica NV
- FibroGen Inc.
- Astellas Pharma Inc.
- Northstar Neuroscience Inc.
- Visicu Inc.
- Hologic Inc.
- AEG Elektrofotografie GmbH
- R2 Technology Inc.
- Suros Surgical Systems Inc.
- Fisher Scientific International Inc.
- Thermo Fisher Scientific Inc.
- Siemens AG
- Diagnostic Products Corp.
- Bayer Diagnostics
- Illumina Inc.
- deCODE genetics EHF
- Renovo completes £57.5mm IPO
- Entelos closes $20mm IPO
- Hutchison China Meditech closes £37mm IPO on AIM
- Medarex nets $128mm with FOPO
- Cougar Biotechnology reverse merges to become public
- Cougar raises $47.5mm in PIPE
- CNS companies Axonyx and TorreyPines reverse merge
- NeuTec Pharma nets £24.5mm from follow-on offering
- AZ to pay £567mm for Cambridge Antibody Technology
- Takeda licenses Affymax's Hematide for Japan; deal ends
- Takeda, Affymax expand Hematide deal; collaboration terminated
- J&J gets rights to Vertex's VX950 for HCV; Janssen buys royalty rights
- FibroGen licenses anemia compounds to Astellas
- Northstar Neuroscience completes $113.9mm IPO
- ICU monitoring company Visicu nets $89mm from IPO
- Hologic buys AEG Elektrofotografie for €21mm
- Hologic acquires R2 Technology
- Hologic acquires Suros Surgical Systems
- Thermo Electron acquires Fisher Scientific in reverse merger
- Siemens buys Bayer Diagnostics for €4.2bn
- Siemens acquires Diagnostic Products for $1.86bn
- Illumina FOPO nets $96.2mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.